Study Finds Molecular Difference in Autistic Brains: Fewer Glutamate Receptors
By
amichail
Pure flour-power. Hearty enough to carry you through lunch.
Summary
Yale School of Medicine researchers have discovered that autistic brains have fewer of a specific type of glutamate receptor compared to neurotypical brains. This molecular difference supports the theory that autism may be driven by a signaling imbalance in the brain. The study, published in The American Journal of Psychiatry, provides new insights into the neurobiological basis of autism spectrum disorder.
Key quotes
· 4 pulledYale School of Medicine (YSM) scientists have discovered a molecular difference in the brains of autistic people compared to their neurotypical counterparts.
Autism is a neurodevelopmental condition associated with behavioral differences including difficulties with social interaction, restrictive or intense interests, and repetitive movements or speech.
Now, a new study in The American Journal of Psychiatry has found that brains of autistic people have fewer of a specific kind of receptor for glutamate, the most common excitatory neurotransmitter.
Brains of autistic individuals have fewer of a specific kind of glutamate receptor, supporting an idea that autism is driven by a signaling imbalance.
You might also wanna read
Japanese researchers develop vitamin K-like compounds that may help convert brain cells into neurons
Japanese researchers have developed a new family of vitamin K-like molecules that may help immature brain cells transition into neurons. Whi
zmescience.com·1d agoGladstone Scientists Develop New Tool to Map Brain Waste Clearance Mechanisms
Gladstone scientists have developed a new tool to trace how the brain clears waste, revealing surprising new biology about the brain's self-
gladstone.org·2d agoTexas A&M researchers develop nasal spray that reverses brain aging in study
Researchers at Texas A&M University have developed a nasal spray that appears to reverse brain aging by reducing inflammation and restoring
Northwestern study identifies schizophrenia biomarker and potential drug candidate for cognitive symptoms
A Northwestern University study in humans and mice has identified a novel biomarker for schizophrenia that could also serve as a drug candid
Salk Institute Study Finds Cannabinoids May Help Remove Alzheimer's-Related Proteins from Brain Cells
Salk Institute researchers have found preliminary evidence that THC and other cannabinoids can promote the cellular removal of amyloid beta
salk.edu·2mo agoOxford Neuroscientists Discover Connection Between Tinnitus and Sleep in the Brain
Neuroscientists at the University of Oxford have discovered a previously overlooked connection between tinnitus and sleep in the brain. Thei
